Efficacy and safety of tralokinumab monotherapy in North American adult patients with moderate-to-severe atopic dermatitis: A subanalysis of the ECZTRA 2 trial

被引：0
|
作者：
Wiseman, Marni [1 ,2 ,3 ]
Armstrong, April W. [4 ]
Soung, Jennifer [5 ,6 ]
Albrecht, Lorne [3 ,7 ]
Lomaga, Mark [3 ,8 ]
Papp, Kim A. [3 ,9 ]
机构：
[1] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Dermatol, Winnipeg, MB, Canada
[3] Prob Med Res, Waterloo, ON, Canada
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[5] Southern Calif Dermatol, Santa Ana, CA USA
[6] Harbor Univ Calif Los Angeles, Los Angeles, CA USA
[7] Enverus Med Res, Surrey, BC, Canada
[8] DermEdge Res, Mississauga, ON, Canada
[9] K Papp Clin Res, Waterloo, ON, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
28186
引用
收藏
页码：AB178 / AB178
页数：1
相关论文
共 50 条
  • [21] SAFETY OF TRALOKINUMAB IN PAEDIATRIC PATIENTS AGED 12-17 WITH MODERATE-TO-SEVERE AROPIC DERMATITIS: RESULTS FROM THE PHASE 3 ECZTRA 6 TRIAL
    Wollenberg, Andreas
    Cork, Michael J.
    Flohr, Carsten
    Bewley, Anthony
    Blauvelt, Andrew
    Hong-H, Chih-Ho
    Imafuku, Shinichi
    Schuttelaar, Marie-Louise Anna
    Simpson, Eric
    Soong, Weily
    Amoudruz, Petra
    Lophaven, Katja
    Kurbasic, Azra
    Soldbro, Lise
    Vest, Natacha
    Paller, Amy
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 58 - 58
  • [22] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
    Schmid-Grendelmeier, Peter
    Gooderham, Melinda J.
    Hartmann, Karin
    Konstantinou, George N.
    Fellmann, Marc
    Koulias, Christopher
    Clibborn, Claire
    Biswas, Pinaki
    Brunner, Patrick M.
    ALLERGY, 2024, 79 (01) : 174 - 183
  • [23] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
    Nettis, Eustachio
    Patella, Vincenzo
    Lombardo, Carla
    Detoraki, Aikaterini
    Macchia, Luigi
    Di Leo, Elisabetta
    Carbonara, Monica
    Canonica, Giorgio W.
    Bonzano, Laura
    ALLERGY, 2020, 75 (10) : 2653 - 2661
  • [24] Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Bewley, Anthony
    Hong, H. Chih-ho
    Silvestre, Juan Francisco
    Peris, Ketty
    Wollenberg, Andreas
    Ivens, Ulla
    Soehoel, Anders
    Steffensen, Louise Abildgaard
    Tindberg, Ann-Marie
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (03) : 410 - 419
  • [25] Safety of amlitelimab in a Phase 2a clinical trial of patients with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Cork, Michael
    Reich, Adam
    Bieber, Thomas
    Gilbert, Sally
    Quaratino, Sonia
    Wilson, Rosamund
    Porter-Brown, Ben
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [26] Safety of Amlitelimab in a Phase 2a Clinical Trial of Patients With Moderate-to-Severe Atopic Dermatitis
    Weidinger, Stephan
    Cork, Michael
    Reich, Adam
    Bieber, Thomas
    Gilbert, Sally
    Quaratino, Sonia
    Wilson, Rosamund
    Porter-Brown, Ben
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB221 - AB221
  • [27] Early changes in patient-relevant endpoints in three tralokinumab pivotal phase III trials (ECZTRA 1-3) in adult patients with moderate-to-severe atopic dermatitis
    Silverberg, J. I.
    Cork, M.
    Wollenberg, A.
    Katoh, N.
    Steffensen, L. A.
    Kurbasic, A.
    Olsen, C. K.
    Kuznetsova, A.
    Osterdal, M. L.
    Vilsboll, A. W.
    Deleuran, M.
    Simpson, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E64 - E64
  • [28] A phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD)
    Wollenberg, Andreas
    Howell, Michael D.
    Guttman-Yassky, Emma
    Silverberg, Jonathan I.
    Birrell, Claire
    Kell, Chris
    Dawson, Michelle
    van der Merwe, Rene
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB20 - AB20
  • [29] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, Saakshi
    Brunner, Patrick M.
    Garcet, Sandra
    Finney, Robert
    Cohen, Steven R.
    Oliva, Margeaux
    Dutt, Riana
    Fuentes-Duculan, Judilyn
    Zheng, Xiuzhong
    Li, Xuan
    Bonifacio, Kathleen M.
    Kunjravia, Norma
    Coats, Israel
    Cueto, Inna
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Suarez-Farinas, Mayte
    Krueger, James G.
    Guttman-Yassky, Emma
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
  • [30] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
12345